Published in Clin Microbiol Rev on October 01, 2007
Comparative genomics reveal the mechanism of the parallel evolution of O157 and non-O157 enterohemorrhagic Escherichia coli. Proc Natl Acad Sci U S A (2009) 3.17
The type III effectors NleE and NleB from enteropathogenic E. coli and OspZ from Shigella block nuclear translocation of NF-kappaB p65. PLoS Pathog (2010) 2.03
Pseudomonas aeruginosa virulence and therapy: evolving translational strategies. Crit Care Med (2009) 1.89
Legionella pneumophila strain 130b possesses a unique combination of type IV secretion systems and novel Dot/Icm secretion system effector proteins. J Bacteriol (2010) 1.64
XopD SUMO protease affects host transcription, promotes pathogen growth, and delays symptom development in xanthomonas-infected tomato leaves. Plant Cell (2008) 1.62
Xanthomonas T3S Effector XopN Suppresses PAMP-Triggered Immunity and Interacts with a Tomato Atypical Receptor-Like Kinase and TFT1. Plant Cell (2009) 1.33
A type III effector protease NleC from enteropathogenic Escherichia coli targets NF-κB for degradation. Mol Microbiol (2011) 1.33
Polar localization of virulence-related Esx-1 secretion in mycobacteria. PLoS Pathog (2009) 1.32
Intrinsic and Extrinsic Regulation of Type III Secretion Gene Expression in Pseudomonas Aeruginosa. Front Microbiol (2011) 1.29
Type V secretion: mechanism(s) of autotransport through the bacterial outer membrane. Philos Trans R Soc Lond B Biol Sci (2012) 1.25
The Leishmania surface protease GP63 cleaves multiple intracellular proteins and actively participates in p38 mitogen-activated protein kinase inactivation. J Biol Chem (2008) 1.22
Enteric infection meets intestinal function: how bacterial pathogens cause diarrhoea. Nat Rev Microbiol (2008) 1.22
Definition of the extracellular proteome of pathogenic-phase Histoplasma capsulatum. J Proteome Res (2011) 1.22
The starting lineup: key microbial players in intestinal immunity and homeostasis. Front Microbiol (2011) 1.16
Identification of bacterial target proteins for the salicylidene acylhydrazide class of virulence-blocking compounds. J Biol Chem (2011) 1.15
Brain damage in newborn rat model of meningitis by Enterobacter sakazakii: a role for outer membrane protein A. Lab Invest (2009) 1.15
Genome comparison of the epiphytic bacteria Erwinia billingiae and E. tasmaniensis with the pear pathogen E. pyrifoliae. BMC Genomics (2010) 1.12
ExsD inhibits expression of the Pseudomonas aeruginosa type III secretion system by disrupting ExsA self-association and DNA binding activity. J Bacteriol (2009) 1.11
Genetic functions of the NAIP family of inflammasome receptors for bacterial ligands in mice. J Exp Med (2016) 1.10
Gene Ontology annotation highlights shared and divergent pathogenic strategies of type III effector proteins deployed by the plant pathogen Pseudomonas syringae pv tomato DC3000 and animal pathogenic Escherichia coli strains. BMC Microbiol (2009) 1.09
Regulation of type VI secretion system during Burkholderia pseudomallei infection. Infect Immun (2011) 1.07
A three-way comparative genomic analysis of Mannheimia haemolytica isolates. BMC Genomics (2010) 1.07
Acquired type III secretion system determines environmental fitness of epidemic Vibrio parahaemolyticus in the interaction with bacterivorous protists. PLoS One (2011) 1.05
A Vibrio parahaemolyticus T3SS effector mediates pathogenesis by independently enabling intestinal colonization and inhibiting TAK1 activation. Cell Rep (2013) 1.04
Change is good: variations in common biological mechanisms in the epsilonproteobacterial genera Campylobacter and Helicobacter. Microbiol Mol Biol Rev (2011) 1.01
Identification of Vibrio cholerae type III secretion system effector proteins. Infect Immun (2011) 1.01
The blueprint of the type-3 injectisome. Philos Trans R Soc Lond B Biol Sci (2012) 1.01
Bacterial macroscopic rope-like fibers with cytopathic and adhesive properties. J Biol Chem (2010) 1.00
SOBER1 phospholipase activity suppresses phosphatidic acid accumulation and plant immunity in response to bacterial effector AvrBsT. Proc Natl Acad Sci U S A (2009) 1.00
In vitro and in vivo model systems for studying enteropathogenic Escherichia coli infections. Cold Spring Harb Perspect Med (2013) 0.99
The common structural architecture of Shigella flexneri and Salmonella typhimurium type three secretion needles. PLoS Pathog (2013) 0.98
The Pseudomonas aeruginosa magnesium transporter MgtE inhibits transcription of the type III secretion system. Infect Immun (2009) 0.98
A refined model of the prototypical Salmonella SPI-1 T3SS basal body reveals the molecular basis for its assembly. PLoS Pathog (2013) 0.98
The Campylobacter jejuni CiaC virulence protein is secreted from the flagellum and delivered to the cytosol of host cells. Front Cell Infect Microbiol (2012) 0.97
Spontaneous formation of IpaB ion channels in host cell membranes reveals how Shigella induces pyroptosis in macrophages. Cell Death Dis (2012) 0.97
The T3SS effector EspT defines a new category of invasive enteropathogenic E. coli (EPEC) which form intracellular actin pedestals. PLoS Pathog (2009) 0.97
IQGAP1 in microbial pathogenesis: Targeting the actin cytoskeleton. FEBS Lett (2011) 0.97
Competition and resilience between founder and introduced bacteria in the Caenorhabditis elegans gut. Infect Immun (2011) 0.96
Fusobacterium nucleatum outer membrane proteins Fap2 and RadD induce cell death in human lymphocytes. Infect Immun (2010) 0.96
Vibrio parahaemolyticus infection induces modulation of IL-8 secretion through dual pathway via VP1680 in Caco-2 cells. J Infect Dis (2010) 0.96
Vp1659 is a Vibrio parahaemolyticus type III secretion system 1 protein that contributes to translocation of effector proteins needed to induce cytolysis, autophagy, and disruption of actin structure in HeLa cells. J Bacteriol (2010) 0.95
Differential expression of type III effector BteA protein due to IS481 insertion in Bordetella pertussis. PLoS One (2011) 0.94
The Lon protease is essential for full virulence in Pseudomonas aeruginosa. PLoS One (2012) 0.93
The Rcs signal transduction pathway is triggered by enterobacterial common antigen structure alterations in Serratia marcescens. J Bacteriol (2010) 0.92
EseG, an effector of the type III secretion system of Edwardsiella tarda, triggers microtubule destabilization. Infect Immun (2010) 0.92
Direct reprogramming of fibroblasts to myocytes via bacterial injection of MyoD protein. Cell Reprogram (2013) 0.91
Composition, formation, and regulation of the cytosolic c-ring, a dynamic component of the type III secretion injectisome. PLoS Biol (2015) 0.90
Structure and protein-protein interaction studies on Chlamydia trachomatis protein CT670 (YscO Homolog). J Bacteriol (2010) 0.90
Metalloprotease NleC suppresses host NF-κB/inflammatory responses by cleaving p65 and interfering with the p65/RPS3 interaction. PLoS Pathog (2015) 0.88
YopD self-assembly and binding to LcrV facilitate type III secretion activity by Yersinia pseudotuberculosis. J Biol Chem (2010) 0.88
Lethality and developmental delay in Drosophila melanogaster larvae after ingestion of selected Pseudomonas fluorescens strains. PLoS One (2010) 0.87
Tomato TFT1 is required for PAMP-triggered immunity and mutations that prevent T3S effector XopN from binding to TFT1 attenuate Xanthomonas virulence. PLoS Pathog (2012) 0.87
Burkholderia pseudomallei suppresses Caenorhabditis elegans immunity by specific degradation of a GATA transcription factor. Proc Natl Acad Sci U S A (2013) 0.86
A dominant-negative needle mutant blocks type III secretion of early but not late substrates in Yersinia. Mol Microbiol (2010) 0.86
The capping domain in RalF regulates effector functions. PLoS Pathog (2012) 0.86
Transcriptome analysis of Vibrio parahaemolyticus in type III secretion system 1 inducing conditions. Front Cell Infect Microbiol (2014) 0.86
Eukaryotic signaling pathways targeted by Salmonella effector protein AvrA in intestinal infection in vivo. BMC Microbiol (2010) 0.86
Dormant intracellular Salmonella enterica serovar Typhimurium discriminates among Salmonella pathogenicity island 2 effectors to persist inside fibroblasts. Infect Immun (2013) 0.85
Pseudomonas aeruginosa injects NDK into host cells through a type III secretion system. Microbiology (2014) 0.85
Recognition of LPS by TLR4: potential for anti-inflammatory therapies. Mar Drugs (2014) 0.85
RNA sequencing analysis of the broad-host-range strain Sinorhizobium fredii NGR234 identifies a large set of genes linked to quorum sensing-dependent regulation in the background of a traI and ngrI deletion mutant. Appl Environ Microbiol (2014) 0.84
Mutations in the Pseudomonas aeruginosa needle protein gene pscF confer resistance to phenoxyacetamide inhibitors of the type III secretion system. Antimicrob Agents Chemother (2014) 0.83
The hydrophilic translocator for Vibrio parahaemolyticus, T3SS2, is also translocated. Infect Immun (2012) 0.83
Salmonella enterica serotype Typhimurium usurps the scaffold protein IQGAP1 to manipulate Rac1 and MAPK signalling. Biochem J (2011) 0.83
IscR is essential for yersinia pseudotuberculosis type III secretion and virulence. PLoS Pathog (2014) 0.83
Laboratory adaptation of Bordetella pertussis is associated with the loss of type three secretion system functionality. Infect Immun (2011) 0.83
Haemophilus ducreyi LspA proteins are tyrosine phosphorylated by macrophage-encoded protein tyrosine kinases. Infect Immun (2008) 0.83
The inflammatory cytokine tumor necrosis factor modulates the expression of Salmonella typhimurium effector proteins. J Inflamm (Lond) (2010) 0.83
Pathogenic Bacterial Proteins and their Anti-Inflammatory Effects in the Eukaryotic Host. Antiinflamm Antiallergy Agents Med Chem (2009) 0.82
Characterization of the pathogenome and phylogenomic classification of enteropathogenic Escherichia coli of the O157:non-H7 serotypes. Pathog Dis (2015) 0.82
The metabolic enzyme AdhE controls the virulence of Escherichia coli O157:H7. Mol Microbiol (2014) 0.81
The bacterial type III secretion system as a target for developing new antibiotics. Chem Biol Drug Des (2015) 0.81
Engineered nanoparticles mimicking cell membranes for toxin neutralization. Adv Drug Deliv Rev (2015) 0.81
DBSecSys: a database of Burkholderia mallei secretion systems. BMC Bioinformatics (2014) 0.81
Flagellar biogenesis of Xanthomonas campestris requires the alternative sigma factors RpoN2 and FliA and is temporally regulated by FlhA, FlhB, and FlgM. J Bacteriol (2009) 0.80
Type IV Secretion System Is Not Involved in Infection Process in Citrus. Int J Microbiol (2014) 0.80
Vibrio parahaemolyticus ExsE is requisite for initial adhesion and subsequent type III secretion system 1-dependent autophagy in HeLa cells. Microbiology (2012) 0.79
Exposure to static magnetic field stimulates quorum sensing circuit in luminescent Vibrio strains of the Harveyi clade. PLoS One (2014) 0.79
The zinc regulated antivirulence pathway of Salmonella is a multiprotein immunoglobulin adhesion system. J Biol Chem (2012) 0.79
Actin-based confinement of calcium responses during Shigella invasion. Nat Commun (2013) 0.79
Fructooligosacharides reduce Pseudomonas aeruginosa PAO1 pathogenicity through distinct mechanisms. PLoS One (2014) 0.79
Small molecules aimed at type III secretion systems to inhibit bacterial virulence. Medchemcomm (2013) 0.79
Multidrug Efflux Pumps at the Crossroad between Antibiotic Resistance and Bacterial Virulence. Front Microbiol (2016) 0.78
A reproducible approach to high-throughput biological data acquisition and integration. PeerJ (2015) 0.78
Characterization of the Shigella and Salmonella Type III Secretion System Tip-Translocon Protein-Protein Interaction by Paramagnetic Relaxation Enhancement. Chembiochem (2016) 0.78
The rise of pathogens: predation as a factor driving the evolution of human pathogens in the environment. Microb Ecol (2013) 0.78
Environmental cues and symbiont microbe-associated molecular patterns function in concert to drive the daily remodelling of the crypt-cell brush border of the Euprymna scolopes light organ. Cell Microbiol (2016) 0.78
Current fluctuation analysis of the PopB and PopD translocon components of the Pseudomonas aeruginosa type III secretion system. Biophys J (2013) 0.77
The Bordetella pertussis type III secretion system tip complex protein Bsp22 is not a protective antigen and fails to elicit serum antibody responses during infection of humans and mice. Infect Immun (2013) 0.77
Vibrio cholerae Porin OmpU Induces Caspase-independent Programmed Cell Death upon Translocation to the Host Cell Mitochondria. J Biol Chem (2015) 0.77
In vivo studies of Clostridium perfringens in mouse gas gangrene model. Curr Microbiol (2010) 0.77
The Role of Bacterial Secretion Systems in the Virulence of Gram-Negative Airway Pathogens Associated with Cystic Fibrosis. Front Microbiol (2016) 0.77
Spread and change in stress resistance of Shiga toxin-producing Escherichia coli O157 on fungal colonies. Microb Biotechnol (2013) 0.76
Synthesis and structure-activity relationships of novel phenoxyacetamide inhibitors of the Pseudomonas aeruginosa type III secretion system (T3SS). Bioorg Med Chem (2015) 0.76
Who's really in control: microbial regulation of protein trafficking in the epithelium. Am J Physiol Cell Physiol (2013) 0.76
Aeromonas spp.-mediated cell-contact cytotoxicity is associated with the presence of type III secretion system. Antonie Van Leeuwenhoek (2011) 0.76
ExsB is required for correct assembly of the Pseudomonas aeruginosa type III secretion apparatus in the bacterial membrane and full virulence in vivo. Infect Immun (2015) 0.76
The Yersinia Type III secretion effector YopM Is an E3 ubiquitin ligase that induced necrotic cell death by targeting NLRP3. Cell Death Dis (2016) 0.76
Post-transcriptional regulation of type III secretion in plant and animal pathogens. Curr Opin Microbiol (2017) 0.76
Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol (2000) 20.70
Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1beta in salmonella-infected macrophages. Nat Immunol (2006) 10.55
Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1beta via Ipaf. Nat Immunol (2006) 9.64
Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol (2001) 9.62
Genome sequence of Vibrio parahaemolyticus: a pathogenic mechanism distinct from that of V cholerae. Lancet (2003) 6.95
Adhesion of enteropathogenic Escherichia coli to human intestinal enterocytes and cultured human intestinal mucosa. Infect Immun (1987) 6.77
Escape of intracellular Shigella from autophagy. Science (2004) 6.64
Identification of a virulence locus encoding a second type III secretion system in Salmonella typhimurium. Proc Natl Acad Sci U S A (1996) 6.42
Target cell contact triggers expression and polarized transfer of Yersinia YopE cytotoxin into mammalian cells. EMBO J (1994) 6.37
Rho GTPases and actin dynamics in membrane protrusions and vesicle trafficking. Trends Cell Biol (2006) 6.33
Shigella flexneri induces apoptosis in infected macrophages. Nature (1992) 6.26
Autophagy controls Salmonella infection in response to damage to the Salmonella-containing vacuole. J Biol Chem (2006) 5.50
S. typhimurium encodes an activator of Rho GTPases that induces membrane ruffling and nuclear responses in host cells. Cell (1998) 5.27
The Salmonella invasin SipB induces macrophage apoptosis by binding to caspase-1. Proc Natl Acad Sci U S A (1999) 5.17
Genes encoding putative effector proteins of the type III secretion system of Salmonella pathogenicity island 2 are required for bacterial virulence and proliferation in macrophages. Mol Microbiol (1998) 5.07
ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury. Mol Microbiol (1997) 4.94
Yersinia YopJ acetylates and inhibits kinase activation by blocking phosphorylation. Science (2006) 4.71
Yersinia outer proteins: role in modulation of host cell signaling responses and pathogenesis. Annu Rev Microbiol (2005) 4.46
A salmonella protein antagonizes Rac-1 and Cdc42 to mediate host-cell recovery after bacterial invasion. Nature (1999) 4.12
Salmonella pathogenicity island 2-dependent evasion of the phagocyte NADPH oxidase. Science (2000) 4.12
Type III protein secretion is associated with death in lower respiratory and systemic Pseudomonas aeruginosa infections. J Infect Dis (2001) 4.06
IpaB of Shigella flexneri causes entry into epithelial cells and escape from the phagocytic vacuole. EMBO J (1992) 3.84
Autophagy promotes MHC class II presentation of peptides from intracellular source proteins. Proc Natl Acad Sci U S A (2005) 3.75
Type III protein secretion is associated with poor clinical outcomes in patients with ventilator-associated pneumonia caused by Pseudomonas aeruginosa. Crit Care Med (2002) 3.63
Identification of a bacterial type III effector family with G protein mimicry functions. Cell (2006) 3.47
Yersinia signals macrophages to undergo apoptosis and YopJ is necessary for this cell death. Proc Natl Acad Sci U S A (1997) 3.43
An injected bacterial effector targets chromatin access for transcription factor NF-kappaB to alter transcription of host genes involved in immune responses. Nat Immunol (2006) 3.41
EspFU is a translocated EHEC effector that interacts with Tir and N-WASP and promotes Nck-independent actin assembly. Dev Cell (2004) 3.36
Plague bacteria target immune cells during infection. Science (2005) 3.32
Salmonella pathogenicity island 2 mediates protection of intracellular Salmonella from reactive nitrogen intermediates. J Exp Med (2002) 3.31
Process of protein transport by the type III secretion system. Microbiol Mol Biol Rev (2004) 3.31
The Salmonella pathogenicity island (SPI)-2 and SPI-1 type III secretion systems allow Salmonella serovar typhimurium to trigger colitis via MyD88-dependent and MyD88-independent mechanisms. J Immunol (2005) 3.14
The mechanism of action of the Pseudomonas aeruginosa-encoded type III cytotoxin, ExoU. EMBO J (2003) 3.10
Functional characterization of two type III secretion systems of Vibrio parahaemolyticus. Infect Immun (2004) 2.92
TccP is an enterohaemorrhagic Escherichia coli O157:H7 type III effector protein that couples Tir to the actin-cytoskeleton. Cell Microbiol (2004) 2.91
The V-antigen of Yersinia forms a distinct structure at the tip of injectisome needles. Science (2005) 2.90
The Salmonella enterica serotype typhimurium effector proteins SipA, SopA, SopB, SopD, and SopE2 act in concert to induce diarrhea in calves. Infect Immun (2002) 2.88
The Shigella flexneri effector OspG interferes with innate immune responses by targeting ubiquitin-conjugating enzymes. Proc Natl Acad Sci U S A (2005) 2.88
Caspase-1 activation of IL-1beta and IL-18 are essential for Shigella flexneri-induced inflammation. Immunity (2000) 2.81
Role of the S. typhimurium actin-binding protein SipA in bacterial internalization. Science (1999) 2.80
Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine. Vaccine (1998) 2.75
A Yersinia effector and a Pseudomonas avirulence protein define a family of cysteine proteases functioning in bacterial pathogenesis. Cell (2002) 2.75
Shigella-induced apoptosis is dependent on caspase-1 which binds to IpaB. J Biol Chem (1998) 2.75
Molecular pathogenesis of Citrobacter rodentium and transmissible murine colonic hyperplasia. Microbes Infect (2001) 2.71
Salmonella typhimurium translocates flagellin across intestinal epithelia, inducing a proinflammatory response. J Clin Invest (2001) 2.67
Genomic characterization of non-O1, non-O139 Vibrio cholerae reveals genes for a type III secretion system. Proc Natl Acad Sci U S A (2005) 2.65
Targeting bacterial virulence: inhibitors of type III secretion in Yersinia. Chem Biol (2003) 2.61
Interleukin 1 is released by murine macrophages during apoptosis induced by Shigella flexneri. J Clin Invest (1994) 2.47
Salmonella entry into host cells: the work in concert of type III secreted effector proteins. Microbes Infect (2001) 2.39
Microbial pathogenesis and cytoskeletal function. Nature (2003) 2.38
The secreted Ipa complex of Shigella flexneri promotes entry into mammalian cells. Proc Natl Acad Sci U S A (1996) 2.37
Salmonella enterica serovar Typhimurium pathogenicity island 2 is necessary for complete virulence in a mouse model of infectious enterocolitis. Infect Immun (2005) 2.32
Type III secretion: more systems than you think. Physiology (Bethesda) (2005) 2.26
IpaD localizes to the tip of the type III secretion system needle of Shigella flexneri. Infect Immun (2006) 2.24
Phagocyte sabotage: disruption of macrophage signalling by bacterial pathogens. Nat Rev Mol Cell Biol (2003) 2.21
IpaC induces actin polymerization and filopodia formation during Shigella entry into epithelial cells. EMBO J (1999) 2.20
Structural and signalling molecules come together at tight junctions. Curr Opin Cell Biol (1999) 2.16
A Salmonella protein causes macrophage cell death by inducing autophagy. J Cell Biol (2003) 2.15
Salmonella modulates vesicular traffic by altering phosphoinositide metabolism. Science (2004) 2.06
EspH, a new cytoskeleton-modulating effector of enterohaemorrhagic and enteropathogenic Escherichia coli. Mol Microbiol (2003) 2.04
Salmonella pathogenicity island 2-encoded type III secretion system mediates exclusion of NADPH oxidase assembly from the phagosomal membrane. J Immunol (2001) 2.04
Small-molecule inhibitors specifically targeting type III secretion. Infect Immun (2005) 2.02
A small-molecule inhibitor of type III secretion inhibits different stages of the infectious cycle of Chlamydia trachomatis. Proc Natl Acad Sci U S A (2006) 2.01
Phosphorylation of the enteropathogenic E. coli receptor by the Src-family kinase c-Fyn triggers actin pedestal formation. Nat Cell Biol (2004) 1.99
Direct nucleation and bundling of actin by the SipC protein of invasive Salmonella. EMBO J (1999) 1.96
The intracellular fate of Salmonella depends on the recruitment of kinesin. Science (2005) 1.92
Control of actin turnover by a salmonella invasion protein. Mol Cell (2004) 1.89
Analysis of the contribution of Salmonella pathogenicity islands 1 and 2 to enteric disease progression using a novel bovine ileal loop model and a murine model of infectious enterocolitis. Infect Immun (2005) 1.88
SipA, SopA, SopB, SopD, and SopE2 contribute to Salmonella enterica serotype typhimurium invasion of epithelial cells. Infect Immun (2005) 1.85
Microtubule-severing activity of Shigella is pivotal for intercellular spreading. Science (2006) 1.85
Pseudomonas aeruginosa induces type-III-secretion-mediated apoptosis of macrophages and epithelial cells. Infect Immun (1999) 1.82
Vaccination against shigellosis with attenuated Shigella flexneri 2a strain SC602. Infect Immun (1999) 1.80
Regions of Yersinia pestis V antigen that contribute to protection against plague identified by passive and active immunization. Infect Immun (1997) 1.77
Decreased shedding of Escherichia coli O157:H7 by cattle following vaccination with type III secreted proteins. Vaccine (2004) 1.77
Identification of proteins secreted via Vibrio parahaemolyticus type III secretion system 1. Infect Immun (2006) 1.76
Elimination of host cell PtdIns(4,5)P(2) by bacterial SigD promotes membrane fission during invasion by Salmonella. Nat Cell Biol (2002) 1.75
Clinical and environmental isolates of Vibrio cholerae serogroup O141 carry the CTX phage and the genes encoding the toxin-coregulated pili. J Clin Microbiol (2001) 1.73
Contribution of the major secreted yops of Yersinia enterocolitica O:8 to pathogenicity in the mouse infection model. Infect Immun (2004) 1.73
Attaching and effacing pathogen-induced tight junction disruption in vivo. Cell Microbiol (2006) 1.73
Co-ordinate regulation of distinct host cell signalling pathways by multifunctional enteropathogenic Escherichia coli effector molecules. Mol Microbiol (2002) 1.71
Taking possession: biogenesis of the Salmonella-containing vacuole. Traffic (2003) 1.70
Salmonella type III secretion effectors: pulling the host cell's strings. Curr Opin Microbiol (2006) 1.70
Targeting Rac1 by the Yersinia effector protein YopE inhibits caspase-1-mediated maturation and release of interleukin-1beta. J Biol Chem (2004) 1.70
Protective anti-V antibodies inhibit Pseudomonas and Yersinia translocon assembly within host membranes. J Infect Dis (2005) 1.67
The plague virulence protein YopM targets the innate immune response by causing a global depletion of NK cells. Infect Immun (2004) 1.66
Generation and characterization of a protective monoclonal antibody to Pseudomonas aeruginosa PcrV. J Infect Dis (2002) 1.61
Shigella's ways of manipulating the host intestinal innate and adaptive immune system: a tool box for survival? Immunol Cell Biol (2007) 1.60
The development of early host response to Pseudomonas aeruginosa lung infection is critically dependent on myeloid differentiation factor 88 in mice. J Biol Chem (2004) 1.58
Intestinal barrier dysfunction by enteropathogenic Escherichia coli is mediated by two effector molecules and a bacterial surface protein. Mol Microbiol (2004) 1.57
Cellular microbiology of intracellular Salmonella enterica: functions of the type III secretion system encoded by Salmonella pathogenicity island 2. Cell Mol Life Sci (2004) 1.55
SseF and SseG are translocated effectors of the type III secretion system of Salmonella pathogenicity island 2 that modulate aggregation of endosomal compartments. Cell Microbiol (2002) 1.55
Shigella flexneri IpaH(7.8) facilitates escape of virulent bacteria from the endocytic vacuoles of mouse and human macrophages. Infect Immun (2000) 1.53
Subversion of actin dynamics by EPEC and EHEC. Curr Opin Microbiol (2006) 1.53
Vaccination against typhoid fever: present status. Bull World Health Organ (1994) 1.52
Autophagy: eating for good health. J Immunol (2006) 1.51
Flagellin/TLR5 responses in epithelia reveal intertwined activation of inflammatory and apoptotic pathways. Am J Physiol Gastrointest Liver Physiol (2005) 1.49
Enteropathogenic Escherichia coli mediates antiphagocytosis through the inhibition of PI 3-kinase-dependent pathways. EMBO J (2001) 1.48
Characterization of Salmonella enterica derivatives harboring defined aroC and Salmonella pathogenicity island 2 type III secretion system (ssaV) mutations by immunization of healthy volunteers. Infect Immun (2002) 1.47
Comparative analysis of EspF from enteropathogenic and enterohemorrhagic Escherichia coli in alteration of epithelial barrier function. Infect Immun (2004) 1.44
Shigella flexneri 2a strain CVD 1207, with specific deletions in virG, sen, set, and guaBA, is highly attenuated in humans. Infect Immun (2000) 1.44
Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe (2008) 11.08
Gut microbiota in health and disease. Physiol Rev (2010) 7.76
Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe (2007) 5.56
Dissecting virulence: systematic and functional analyses of a pathogenicity island. Proc Natl Acad Sci U S A (2004) 5.34
Molecular mechanisms of Escherichia coli pathogenicity. Nat Rev Microbiol (2010) 4.13
Muc2 protects against lethal infectious colitis by disassociating pathogenic and commensal bacteria from the colonic mucosa. PLoS Pathog (2010) 3.76
Antibiotic-induced perturbations of the intestinal microbiota alter host susceptibility to enteric infection. Infect Immun (2008) 3.68
Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe (2007) 3.28
Manipulation of host-cell pathways by bacterial pathogens. Nature (2007) 2.89
Virulence factors of the human opportunistic pathogen Serratia marcescens identified by in vivo screening. EMBO J (2003) 2.87
The caspase-1 inflammasome: a pilot of innate immune responses. Cell Host Microbe (2008) 2.71
Evidence of a large novel gene pool associated with prokaryotic genomic islands. PLoS Genet (2005) 2.71
Invasive and adherent bacterial pathogens co-Opt host clathrin for infection. Cell Host Microbe (2007) 2.53
Identification and characterization of NleA, a non-LEE-encoded type III translocated virulence factor of enterohaemorrhagic Escherichia coli O157:H7. Mol Microbiol (2004) 2.51
Pathogenicity islands: a molecular toolbox for bacterial virulence. Cell Microbiol (2006) 2.44
Recent advances in understanding enteric pathogenic Escherichia coli. Clin Microbiol Rev (2013) 2.43
Shifting the balance: antibiotic effects on host-microbiota mutualism. Nat Rev Microbiol (2011) 2.43
Microbial pathogenesis and cytoskeletal function. Nature (2003) 2.38
Salmonella enterica serovar Typhimurium pathogenicity island 2 is necessary for complete virulence in a mouse model of infectious enterocolitis. Infect Immun (2005) 2.32
Clearance of Citrobacter rodentium requires B cells but not secretory immunoglobulin A (IgA) or IgM antibodies. Infect Immun (2004) 2.32
Citrobacter rodentium translocated intimin receptor (Tir) is an essential virulence factor needed for actin condensation, intestinal colonization and colonic hyperplasia in mice. Mol Microbiol (2003) 2.21
Phagocyte sabotage: disruption of macrophage signalling by bacterial pathogens. Nat Rev Mol Cell Biol (2003) 2.21
Structural characterization of the molecular platform for type III secretion system assembly. Nature (2005) 2.20
Host susceptibility to the attaching and effacing bacterial pathogen Citrobacter rodentium. Infect Immun (2003) 2.17
Quorum sensing in bacterial virulence. Microbiology (2010) 2.15
Chronic enteric salmonella infection in mice leads to severe and persistent intestinal fibrosis. Gastroenterology (2008) 2.05
A conserved structural motif mediates formation of the periplasmic rings in the type III secretion system. Nat Struct Mol Biol (2009) 2.02
Interplay between antibacterial effectors: a macrophage antimicrobial peptide impairs intracellular Salmonella replication. Proc Natl Acad Sci U S A (2004) 2.00
The invasion-associated type III secretion system of Salmonella enterica serovar Typhimurium is necessary for intracellular proliferation and vacuole biogenesis in epithelial cells. Cell Microbiol (2002) 2.00
An anti-infective peptide that selectively modulates the innate immune response. Nat Biotechnol (2007) 1.97
Analysis of the contribution of Salmonella pathogenicity islands 1 and 2 to enteric disease progression using a novel bovine ileal loop model and a murine model of infectious enterocolitis. Infect Immun (2005) 1.88
Toll-like receptor 4 contributes to colitis development but not to host defense during Citrobacter rodentium infection in mice. Infect Immun (2006) 1.87
Molecular analysis as an aid to assess the public health risk of non-O157 Shiga toxin-producing Escherichia coli strains. Appl Environ Microbiol (2008) 1.84
Defining a healthy human gut microbiome: current concepts, future directions, and clinical applications. Cell Host Microbe (2012) 1.81
Expression and secretion of Salmonella pathogenicity island-2 virulence genes in response to acidification exhibit differential requirements of a functional type III secretion apparatus and SsaL. J Biol Chem (2004) 1.81
The role of the intestinal microbiota in enteric infection. J Physiol (2009) 1.80
A positive regulatory loop controls expression of the locus of enterocyte effacement-encoded regulators Ler and GrlA. J Bacteriol (2005) 1.77
Decreased shedding of Escherichia coli O157:H7 by cattle following vaccination with type III secreted proteins. Vaccine (2004) 1.77
Elimination of host cell PtdIns(4,5)P(2) by bacterial SigD promotes membrane fission during invasion by Salmonella. Nat Cell Biol (2002) 1.75
The enemy within us: lessons from the 2011 European Escherichia coli O104:H4 outbreak. EMBO Mol Med (2012) 1.75
The Salmonella effector protein SopB protects epithelial cells from apoptosis by sustained activation of Akt. J Biol Chem (2005) 1.74
Negative regulation of Salmonella pathogenicity island 2 is required for contextual control of virulence during typhoid. Proc Natl Acad Sci U S A (2005) 1.73
Attaching and effacing pathogen-induced tight junction disruption in vivo. Cell Microbiol (2006) 1.73
Mice lacking T and B lymphocytes develop transient colitis and crypt hyperplasia yet suffer impaired bacterial clearance during Citrobacter rodentium infection. Infect Immun (2002) 1.73
Evidence that plant-like genes in Chlamydia species reflect an ancestral relationship between Chlamydiaceae, cyanobacteria, and the chloroplast. Genome Res (2002) 1.72
Toll-like receptor 4 dependence of innate and adaptive immunity to Salmonella: importance of the Kupffer cell network. J Immunol (2004) 1.67
Salmonella type III effectors PipB and PipB2 are targeted to detergent-resistant microdomains on internal host cell membranes. Mol Microbiol (2003) 1.67
Secretin of the enteropathogenic Escherichia coli type III secretion system requires components of the type III apparatus for assembly and localization. Infect Immun (2003) 1.67
Effect of antibiotic treatment on the intestinal metabolome. Antimicrob Agents Chemother (2011) 1.64
SopB promotes phosphatidylinositol 3-phosphate formation on Salmonella vacuoles by recruiting Rab5 and Vps34. J Cell Biol (2008) 1.64
Bacterial effector binding to ribosomal protein s3 subverts NF-kappaB function. PLoS Pathog (2009) 1.61
Translocated intimin receptor and its chaperone interact with ATPase of the type III secretion apparatus of enteropathogenic Escherichia coli. J Bacteriol (2003) 1.58
SifA, a type III secreted effector of Salmonella typhimurium, directs Salmonella-induced filament (Sif) formation along microtubules. Traffic (2002) 1.57
The intestinal microbiota plays a role in Salmonella-induced colitis independent of pathogen colonization. PLoS One (2011) 1.57
Gap junction hemichannels contribute to the generation of diarrhoea during infectious enteric disease. Gut (2009) 1.56
Disruption of the Salmonella-containing vacuole leads to increased replication of Salmonella enterica serovar typhimurium in the cytosol of epithelial cells. Infect Immun (2002) 1.56
Salmonella impairs RILP recruitment to Rab7 during maturation of invasion vacuoles. Mol Biol Cell (2004) 1.56
Bacterial genetic determinants of non-O157 STEC outbreaks and hemolytic-uremic syndrome after infection. J Infect Dis (2006) 1.52
Regulation of type III secretion hierarchy of translocators and effectors in attaching and effacing bacterial pathogens. Infect Immun (2005) 1.51
Salmonella effectors within a single pathogenicity island are differentially expressed and translocated by separate type III secretion systems. Mol Microbiol (2002) 1.51
Salmonella pathogenicity island 2 is expressed prior to penetrating the intestine. PLoS Pathog (2005) 1.50
Crossing the line: selection and evolution of virulence traits. PLoS Pathog (2006) 1.49
Tight junctions as targets of infectious agents. Biochim Biophys Acta (2008) 1.47
The Salmonella enterica serovar typhimurium divalent cation transport systems MntH and SitABCD are essential for virulence in an Nramp1G169 murine typhoid model. Infect Immun (2004) 1.46
Pathogenesis of enteric Salmonella infections. Curr Opin Gastroenterol (2008) 1.46
Structural analysis of the essential self-cleaving type III secretion proteins EscU and SpaS. Nature (2008) 1.45
Molecular mechanisms of Salmonella virulence and host resistance. Curr Top Microbiol Immunol (2009) 1.45
The role of the immune system in governing host-microbe interactions in the intestine. Nat Immunol (2013) 1.41
Structural analysis of a prototypical ATPase from the type III secretion system. Nat Struct Mol Biol (2007) 1.40
Salmonella infection of gallbladder epithelial cells drives local inflammation and injury in a model of acute typhoid fever. J Infect Dis (2009) 1.39
Host-pathogen interactions: Host resistance factor Nramp1 up-regulates the expression of Salmonella pathogenicity island-2 virulence genes. Proc Natl Acad Sci U S A (2002) 1.39
Transcriptional inhibitor of virulence factors in enteropathogenic Escherichia coli. Antimicrob Agents Chemother (2005) 1.38
Visualization of vacuolar acidification-induced transcription of genes of pathogens inside macrophages. Mol Biol Cell (2005) 1.37
Structural characterization of a type III secretion system filament protein in complex with its chaperone. Nat Struct Mol Biol (2004) 1.37
Citrobacter rodentium infection causes both mitochondrial dysfunction and intestinal epithelial barrier disruption in vivo: role of mitochondrial associated protein (Map). Cell Microbiol (2006) 1.35
Salmonella enterica serovar Typhimurium effectors SopB, SopE, SopE2 and SipA disrupt tight junction structure and function. Cell Microbiol (2006) 1.34
SopD2 is a novel type III secreted effector of Salmonella typhimurium that targets late endocytic compartments upon delivery into host cells. Traffic (2003) 1.33
Modulation of inducible nitric oxide synthase expression by the attaching and effacing bacterial pathogen citrobacter rodentium in infected mice. Infect Immun (2002) 1.29
The gut microbiota: challenging immunology. Nat Rev Immunol (2011) 1.28
The related effector proteins SopD and SopD2 from Salmonella enterica serovar Typhimurium contribute to virulence during systemic infection of mice. Mol Microbiol (2004) 1.27
The bacterial virulence factor NleA inhibits cellular protein secretion by disrupting mammalian COPII function. Cell Host Microbe (2007) 1.27
CesT is a multi-effector chaperone and recruitment factor required for the efficient type III secretion of both LEE- and non-LEE-encoded effectors of enteropathogenic Escherichia coli. Mol Microbiol (2005) 1.27
Bacterial pathogenesis: exploiting cellular adherence. Curr Opin Cell Biol (2003) 1.27
Aquaporins contribute to diarrhoea caused by attaching and effacing bacterial pathogens. Cell Microbiol (2006) 1.27
Salmonella enterica serovar Typhimurium effector SigD/SopB is membrane-associated and ubiquitinated inside host cells. Cell Microbiol (2002) 1.25
Virulence is positively selected by transmission success between mammalian hosts. Curr Biol (2007) 1.23
Salmonella: from pathogenesis to therapeutics. J Bacteriol (2006) 1.22
A deficiency in the autophagy gene Atg16L1 enhances resistance to enteric bacterial infection. Cell Host Microbe (2013) 1.21
The phosphoinositide phosphatase SopB manipulates membrane surface charge and trafficking of the Salmonella-containing vacuole. Cell Host Microbe (2010) 1.20
Mn2+ and bacterial pathogenesis. Front Biosci (2004) 1.19
Citrobacter rodentium virulence in mice associates with bacterial load and the type III effector NleE. Microbes Infect (2007) 1.19
Genetic and molecular analysis of GogB, a phage-encoded type III-secreted substrate in Salmonella enterica serovar typhimurium with autonomous expression from its associated phage. J Mol Biol (2005) 1.18
SseL is a salmonella-specific translocated effector integrated into the SsrB-controlled salmonella pathogenicity island 2 type III secretion system. Infect Immun (2006) 1.18
Delivery of dangerous goods: type III secretion in enteric pathogens. Int J Med Microbiol (2002) 1.17
Macrophages inhibit Salmonella typhimurium replication through MEK/ERK kinase and phagocyte NADPH oxidase activities. J Biol Chem (2002) 1.17
Salmonella enterica serovar Senftenberg human clinical isolates lacking SPI-1. J Clin Microbiol (2008) 1.17